Richard Jacroux
CIK: 0002033818
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NDRA
ENDRA Life Sciences Inc.
Officer
Discretionary Trading P&L
Holdings
About Jacroux Richard
Jacroux Richard (SEC CIK 0002033818) files insider reports with the SEC as Chief Financial Officer of ENDRA Life Sciences Inc. (NDRA).
Signal8 holds 2 ownership filings by Jacroux Richard, all Form 4s, filed between Jan 23, 2026 and Mar 4, 2026. Those filings report 2 transactions, from Jan 21, 2026 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jacroux Richard's filings is in ANN ARBOR, MI.
Recent filings by Jacroux Richard
Other insiders filing for ENDRA Life Sciences Inc. (NDRA)
- ASP Isotopes Inc., 10% Owner
- Tokman Alexander Y, Chief Executive Officer
- DIGIANDOMENICO ANTHONY, Director
- Harsh Michael, Director
- Basenese Lou, Director
- UBS Group AG, Officer